logo
Kennedy targets vaccination injury program

Kennedy targets vaccination injury program

The Hill3 days ago
Health secretary Robert F. Kennedy Jr. is targeting a little-known but crucial program that underpins all childhood vaccinations.
Kennedy took to social media and the show of conservative activist Charlie Kirk this week to rail against the Vaccine Injury Compensation Program and pledge significant changes.
'The VICP is broken, and I intend to fix it,' he wrote on social platform X. 'I will not allow the VICP to continue to ignore its mandate and fail its mission of quickly and fairly compensating vaccine-injured individuals.'
Attorneys and other experts say Kennedy is right that the program, which was created in 1986 in order to give quick payouts to families who can prove a child was injured from a vaccine, is badly in need of modernization.
'There's a lot of low hanging fruit that [Kennedy] can act on that would immediately alter the course of the vaccine program for the better,' said David Carney, a vaccine injury attorney in Philadelphia and president of the Vaccine Injured Petitioners Bar Association.
Cases could be settled quicker, rather than going through a trial, Carney said. Kennedy could also press Congress to act on legislation that would increase the court staff, increase the pain and suffering caps, and add COVID-19 vaccines to the list of shots eligible for the program.
It has too few staff available to handle a massive caseload, leaving patients waiting for years just to have their cases heard. It covers almost three times as many vaccines as when it was first created, but the number of 'special masters' who hear cases has stayed the same.
Attorneys who argue vaccine injuries said the government has been more favorable to vaccines than petitioners in recent years, fighting against claims that would have previously been easily settled.
'It's not the fast, informal, petitioner-friendly program that Congress designed. It is very adversarial and litigious. That's absolutely, 100% true,' said Renée Gentry, director of the Vaccine Injury Litigation Clinic at George Washington University Law School.
But there's fear the changes Kennedy wants will undermine the program, or tear it down entirely, risking driving drugmakers from the market and threatening access to childhood shots.
Kennedy has long targeted the VICP, and his X post echoed many of his previous arguments. He did not elaborate on what changes he is making but said he is working with Attorney General Pam Bondi.
He has previously said he wants to expand the program, making it easier for claimants to qualify for awards based on adverse events he claims are associated with vaccines but are not currently part of the program.
People can prove injuries two ways, said Dorit Reiss, a vaccine law expert and law professor at UC San Francisco. Either you fit into the table of injuries, and then there's a presumption that the vaccine caused the harm, or you have to show causation for an injury outside the list.
Kennedy has the power to add new injuries to the eligible list, like autism, which he has repeatedly linked to vaccines.
In an interview with Tucker Carlson earlier in July, Kennedy also suggested vaccines are linked to numerous chronic ailments like diabetes and narcolepsy.
'We have now this epidemic of immune dysregulation in our country, and there's no way to rule out vaccines as one of the key culprits,' Kennedy said.
In order to add an injury to the list, Kennedy would have to go through the federal government's cumbersome notice-and-comment rulemaking process. Experts said it's usually a time consuming and expensive undertaking, and often the scientific reviews don't show enough evidence to prove if the vaccine caused harm or not.
Kennedy could also unofficially start settling cases for more injuries without adding them to the list.
Yet either change could risk bankrupting the program.
Families are paid through a trust fund that's funded by an excise tax on vaccine makers, so there's a finite pot of money available. The program's fund covers lawyers' fees and the costs, even for losing cases.
In exchange for the tax, vaccine makers have a limited liability shield. Petitioners file claims against the federal government, not the manufacturers, and families can get compensation without having to prove that drugmakers were negligent.
Kennedy has suggested he wants to change that.
'The VICP has devolved into a morass of inefficiency, favoritism, and outright corruption as government lawyers and the Special Masters who serve as Vaccine Court judges prioritize the solvency of the HHS Trust Fund, over their duty to compensate victims,' Kennedy wrote.
An HHS spokesman declined to say what, if any changes Kennedy is considering, saying the secretary's comments speak for itself.
A popular anti-vaccine talking point is the desire to eliminate the vaccine makers' limited liability shield. But that's only something Congress can do.
Kennedy does have the power to drop vaccines from the program. Right now, it covers 16 routinely recommended immunizations for children or pregnant women. But if a shot is no longer routinely recommended, it can be removed.
In early June, Kennedy abruptly fired all members of the outside advisory group responsible for making vaccine recommendations. He appointed a new group of hand-picked replacements.
If that group no longer recommends the HPV vaccine, for instance, Kennedy can revise the injury table to remove it.
'If he takes it away, then those people have no right to be in this program, and they're going to have to be stuck with civil litigation,' said Gentry, which is much more difficult and expensive.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

RFK Jr., Vaccines and the Trial Bar
RFK Jr., Vaccines and the Trial Bar

Wall Street Journal

timean hour ago

  • Wall Street Journal

RFK Jr., Vaccines and the Trial Bar

The plaintiffs bar has few restraints on its legal marauding on business and government, and now it's about to dismantle a rare oasis of legal sanity. That's the no-fault Vaccine Injury Compensation Program, which is being targeted by the trial bar's agent in the Trump Administration, Robert F. Kennedy Jr. 'The VICP has devolved into a morass of inefficiency, favoritism, and outright corruption,' Mr. Kennedy tweeted last week. He means that the program makes it harder for his trial lawyer friends to shake down vaccine makers. Congress established the VICP in 1986 as a flood of lawsuits were driving manufacturers out of the market. The program established special vaccine courts to review evidence and arbitrate claims. Patients are compensated from a trust fund, which is financed by a 75 cent excise tax on every vaccine sold. They have three years from their injury onset to bring claims. And they can automatically receive compensation for certain conditions that the government has linked to vaccines if their symptoms develop within a specified period of receiving a shot—for example, seven to 42 days for chronic arthritis for vaccines containing the rubella virus.

ACA premiums set to spike
ACA premiums set to spike

The Hill

time2 hours ago

  • The Hill

ACA premiums set to spike

The proposed rates are preliminary and could change before being finalized in late summer. The analysis includes proposed rate changes from 312 insurers in all 50 states and DC. It's the largest rate change insurers have requested since 2018, the last time that policy uncertainty contributed to sharp premium increases. On average, ACA marketplace insurers are raising premiums by about 20 percent in 2026, KFF found. Insurers said they wanted higher premiums to cover rising health care costs, like hospitalizations and physician care, as well as prescription drug costs. Tariffs on imported goods could play a role in rising medical costs, but insurers said there was a lot of uncertainty around implementation, and not many insurers were citing tariffs as a reason for higher rates. But they are adding in higher increases due to changes being made by the Trump administration and Republicans in Congress. For instance, the majority of insurers said they are taking into account the potential expiration of enhanced premium tax credits. Those subsidies, put in place during the COVID-19 pandemic, are set to expire at the end of the year, and there are few signs that Republicans are interested in tackling the issue at all. If Congress takes no action, premiums for subsidized enrollees are projected to increase by over 75 percent starting in January 2026, according to KFF. But some states are pushing back. Arkansas Gov. Sarah Huckabee Sanders (R) on Wednesday called on the state's insurance commissioner to disapprove the proposed increases from Centene and Blue Cross Blue Shield. The companies filed increases of up to 54 percent and 25.5 percent, respectively, she said. 'Arkansas' Insurance Commissioner is required to disapprove of proposed rate increases if they are excessive or discriminatory, and these are both,' Huckabee Sanders said in a statement. 'I'm calling on my Commissioner to follow the law, reject these insane rate increases, and protect Arkansans.'

Huge cuts to mRNA research spark fears about future pandemics
Huge cuts to mRNA research spark fears about future pandemics

The Hill

time3 hours ago

  • The Hill

Huge cuts to mRNA research spark fears about future pandemics

Health Secretary Robert F. Kennedy Jr.'s decision this week to cancel hundreds of millions of dollars in mRNA vaccine funding will leave the United States unprepared for the next pandemic and other public health emergencies, public health experts warned. 'I've tried to be objective & non-alarmist in response to current HHS actions—but quite frankly this move is going to cost lives,' President Trump's former surgeon general Jerome Adams said in a post to X. 'mRNA technology has uses that go far beyond vaccines… and the vaccine they helped develop in record time is credited with saving millions.' The first COVID-19 mRNA vaccines from Pfizer and Moderna hit the market in 2021, just a year after the virus first appeared. Vaccines typically take years to develop, but the mRNA shots were developed in record time due to a massive influx of funding from the first Trump administration, dubbed Operation Warp Speed. The COVID shots proved safe and effective, and helped bring about an end to the pandemic. Experts say mRNA technology has the potential to revolutionize treatments for evolving pathogens, especially bird flu, because the platform can be easily modified. On Tuesday, Kennedy cancelled $500 million worth of contracts related to mRNA vaccine research being funded by the Biomedical Advanced Research and Development Authority. Instead, he said the agency will focus on platforms with 'stronger safety records.' Public health experts point out that reviews of the hundreds of millions, if not billions, of doses of mRNA shots administered worldwide have found very few adverse events. 'It's pretty clear that the administration, or at least the secretary, has a political vendetta not just against vaccines but against mRNA in general,' said Jeff Coller, a professor of RNA biology and therapeutics at Johns Hopkins University. Coller said the move will put the U.S. behind other nations in biomedical research and sends a 'clear message' to scientists and the industry that it is not wise to invest in mRNA technology because if they do, they will likely not receive funding or approval from the federal government. Jennifer Nuzzo, a professor of epidemiology and director of the Pandemic Center at Brown University School of Public Health, told The Hill that the cancellation is a threat to national security, as it opens the U.S. to future public health emergencies caused by biological warfare. 'One of the ways that we deter that from happening is to say the United States is absolutely committed to preparedness,' Nuzzo said. 'When we take them off the table and leave nothing in their place, we basically signal to our adversaries that we are no longer interested in defending ourselves.' In the long run, Nuzzo said, winding down research efforts on mRNA vaccine platforms will stifle medical innovation coming out of the U.S., including new treatments for diseases like cancer. 'It's troubling on a number of fronts,' she said. MRNA vaccines work by sending instructions to cells to make a specific type of protein found on the outer membrane of a virus. The body's immune system is then able to recognize that protein as something foreign and will create antibodies to fight it. That same general approach could be used to help potentially vaccinate someone against a particular cancer, according to Nuzzo. 'Cancers have a genetic signature,' she said. 'We don't know what's going to happen but there are some preliminary studies that suggest it could be a very promising way to treat cancers.' None of the canceled contracts directly deal with cancer research, but the move will likely cause a chilling effect among researchers that ultimately impacts cancer-related work, said Michael Osterholm, founding director of the Center for Infectious Disease Research and Policy and member of the Vaccine Integrity Project. 'I think you're going to see anyone who is willing to invest in mRNA technology, pulling back, if not completely, getting out of this business,' he said. 'This is terribly unfortunate, given that we have a number of other infectious diseases for which this vaccine platform was being explored in terms of taking on other infectious diseases and including some cancer vaccines.' Kennedy is deeply skeptical of vaccines in general, and mRNA vaccines in particular. In 2021, he falsely said the mRNA COVID-19 vaccine was the 'deadliest vaccine ever made.' Kennedy has also been facing pressure from fellow anti-vaccine activists for not doing enough to keep mRNA vaccines off the market. He was criticized earlier this year when the Food and Drug Administration approved Moderna's updated COVID-19 vaccine, even though the agency limited its use in children. In a video posted to X on Tuesday, Kennedy falsely claimed mRNA shots don't protect against respiratory viruses and don't work if a virus mutates. 'One mutation and the vaccine becomes ineffective,' Kennedy said. Following the announcement, public health experts urged Congress to restore funding towards mRNA vaccine research, with some calling it an 'assault' on federal vaccine policy. 'The HHS Secretary continues a mindless assault on sound federal vaccine policy,' said Robert Steinbrook, director of the Public Citizen Health Reseach Group. 'The mRNA vaccine platform was essential to rapid vaccine development and deployment during the COVIVD-19 pandemic and remains essential to preparing for future public health emergencies.' But the full extent of Kennedy's move isn't known. A Moderna spokesperson told The Hill that they were not aware of any new award cancellations since their contract to help develop an H5N1 bird flu vaccine was canceled in May. Gritstone Bio, another company on the HHS list of cancelled contracts, ceased operations earlier this year after the company filed for bankruptcy in 2024. A spokesperson for Tiba Bio said HHS's decision to terminate their BARDA contract 'comes as a surprise' since its contract was for a therapeutic, not a vaccine, and it does not use mRNA technology. Instead, it uses a method called RNA interference, which the FDA approved to treat some diseases in 2018.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store